Condition
Liver Cancer (Primary and Metastatic) clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Liver Cancer (Primary and Metastatic) clinical trials that are recruiting, at sites in 5 countries (most in China (4), Italy (1), France (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 5Countries
Newest Liver Cancer (Primary and Metastatic) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Risk-stratified approach to catching liver cancer earlier in people with chronic liver disease | — | Shenzhen, Guangdong | Recruiting | Sep 15, 2026 |
| Registry of Minimally Invasive Cancer Treatments Using Spectral Angio-CT Guidance | — | Lyon, Auvergne-Rhône-Alpes and 2 other locations | Recruiting | Jun 9, 2026 |
| Liver Cancer Care: Tracking Real-World Diagnoses and Treatments at Tongji Hospital | — | Wuhan, Hubei | Recruiting | May 14, 2026 |
| Combined multimodal tumor therapy system for liver cancer | — | Shanghai, Shanghai Municipality | Recruiting | Mar 9, 2026 |
| Italian registry of techniques to grow the liver before surgery | — | Bologna, Bologna | Recruiting | Mar 3, 2026 |
| EBNK-001 allogeneic NK cell therapy with low-dose IL-15, with or without pembrolizumab, for advanced solid tumors | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Feb 13, 2026 |
| Spectral CT during embolization and ablation for liver and kidney tumors | — | Palo Alto, California | Recruiting | Dec 26, 2025 |
All recruiting trials (7)
-
Risk-stratified approach to catching liver cancer earlier in people with chronic liver disease
This study tests whether a standardized risk-based management plan can help diagnose liver cancer earlier in people who have chronic liver disease.
-
Registry of Minimally Invasive Cancer Treatments Using Spectral Angio-CT Guidance
This registry collects data from adults undergoing image-guided, minimally invasive cancer treatments to see if spectral angio-CT guidance helps predict outcomes and improve planning.
-
Liver Cancer Care: Tracking Real-World Diagnoses and Treatments at Tongji Hospital
This study blindly follows adults with liver cancer at Tongji Hospital to see how different treatments work in real-world care over time.
-
Combined multimodal tumor therapy system for liver cancer
Aims to test a multimodal tumor treatment that combines thermal ablation with immune-based approaches for adults with primary or metastatic liver cancer who can’t have surgery.
-
Italian registry of techniques to grow the liver before surgery
This project will see how hospitals across Italy use different techniques to make the liver grow before surgery for adults with liver tumors.
-
EBNK-001 allogeneic NK cell therapy with low-dose IL-15, with or without pembrolizumab, for advanced solid tumors
This treatment tests an off-the-shelf NK cell product (EBNK-001) given with low-dose IL-15, either alone or with pembrolizumab, in adults with advanced or metastatic solid tumors who have exhausted standard options.
-
Spectral CT during embolization and ablation for liver and kidney tumors
This pilot tries a new spectral CT technique during image-guided embolization and ablation for adults with liver or kidney tumors to see if it improves image quality and helps guide treatment.
Related topics
Quick answers
How many Liver Cancer (Primary and Metastatic) clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (4 trials), Italy (1 trial), France (1 trial), Netherlands (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.